Why Shares of Amyris Are Plummeting This Week
Consistent with the falling temperatures outside, investors are turning a cold shoulder to synthetic biology specialist Amyris (NASDAQ: AMRS) this week. As of the close of the trading session on Thursday, shares of Amyris have plunged 47% from their closing price of $14.09 last Friday.
While the major catalyst for the stock's decline is the company's uninspiring third-quarter 2021 earnings report, shareholders are also likely hitting the sell button in response to the company's capital raise as well as Wall Street's unfavorable take on the stock.
Image source: Getty Images.
Source Fool.com
